Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma. (Record no. 18314870)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02140 a2200649 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515141104.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200905s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1476-5594 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1038/onc.2008.385 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Noborio-Hatano, K |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20090507 |
245 00 - TITLE STATEMENT | |
Title | Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Oncogene |
Date of publication, distribution, etc. | Jan 2009 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 231-42 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Apoptosis |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Boronic Acids |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bortezomib |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Adhesion |
General subdivision | physiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Adhesion Molecules |
General subdivision | physiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Line, Tumor |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dexamethasone |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Down-Regulation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Doxorubicin |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Resistance, Neoplasm |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gene Expression Regulation, Neoplastic |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gene Knockdown Techniques |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Integrin alpha Chains |
General subdivision | biosynthesis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Integrin alpha4 |
General subdivision | biosynthesis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Integrin alpha4beta1 |
General subdivision | physiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Multiple Myeloma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Proteins |
General subdivision | biosynthesis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrazines |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vincristine |
General subdivision | pharmacology |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kikuchi, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Takatoku, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shimizu, R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wada, T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ueda, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nobuyoshi, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Oh, I |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sato, K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Suzuki, T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ozaki, K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mori, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nagai, T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Muroi, K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kano, Y |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Furukawa, Y |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ozawa, K |
773 0# - HOST ITEM ENTRY | |
Title | Oncogene |
Related parts | vol. 28 |
-- | no. 2 |
-- | p. 231-42 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1038/onc.2008.385">https://doi.org/10.1038/onc.2008.385</a> |
Public note | Available from publisher's website |
No items available.